Clinical trial
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
NCT00076232 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00076232 |
|---|---|
| Title | A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High-Risk HSV-2 Seropositive, HIV Seronegative Individuals |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity, Herpes Genitalis |
| Intervention type | Drug |
| Interventions | Acyclovir, Acyclovir placebo |
| Enrollment | 3,682 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 16, 2004 |
| Last update posted | Dec 30, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: